Toward a hierarchy of mechanisms in CaMKII-mediated arrhythmia

Frontiers in Pharmacology

Volumn 5 MAY, Issue , 2014, Pages

  Vincent, Kevin P ^a   McCulloch, Andrew D ^a,b   Edwards, Andrew G ^a,c,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^d SIMULA RESEARCH LABORATORY   (Norway)

Author keywords

Afterdepolarizations; Arrhythmias; CaMKII; Cardiovascular diseases; Ryanodine receptor

Indexed keywords

ANKYRIN; ANKYRIN B; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM ION; RYANODINE RECEPTOR 2; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG;

ANKB GENE; ANKYRIN B SYNDROME; ARRHYTHMOGENESIS; CALCIUM HOMEOSTASIS; CALCIUM TRANSPORT; CAMKII GENE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CONGENITAL HEART DISEASE; ENZYME ACTIVITY; GENE; GENE MUTATION; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; LONG QT SYNDROME; NONHUMAN; POSITIVE FEEDBACK; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SARCOPLASMIC RETICULUM; SINUS NODE DISEASE; TIMOTHY SYNDROME;

EID: 84904659830     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00110     Document Type: Review

References (99)

1. 2+ leak in heart failure. Circ. Res. 97, 1314-1322. doi: 10.1161/01.RES.0000194329.41863.89
2. Aiba, T., Barth, A. S., Hesketh, G. G., Hashambhoy, Y. L., Chakir, K., Tunin, R. S., et al. (2013). Cardiac resynchronization therapy improves altered Na channel gating in canine model of dyssynchronous heart failure. Circ. Arrhythm. Electrophysiol. 6, 546-554. doi: 10.1161/CIRCEP.113.000400
3. Aiba, T., Hesketh, G. G., Barth, A. S., Liu, T., Daya, S., Chakir, K., et al. (2009). Electrophysiological consequences of dyssynchronous heart failure and its restoration by resynchronization therapy. Circulation 119, 1220-1230. doi: 10.1161/CIRCULATIONAHA.108.794834
4. 2+ current in rabbit ventricular myocytes. Circ. Res. 75, 854-861. doi: 10.1161/01.RES.75.5.854
5. 2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites. J. Biol. Chem. 287, 19856-19869. doi: 10.1074/jbc.M111.322537
6. Backs, J., Song, K., Bezprozvannaya, S., Chang, S., and Olson, E. N. (2006). CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116, 1853-1864. doi: 10.1172/JCI27438
7. Barrett, C. F., and Tsien, R. W. (2008). The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proc. Natl. Acad. Sci. U.S.A. 105, 2157-2162. doi: 10.1073/pnas.0710501105
8. Belevych, A. E., Terentyev, D., Terentyeva, R., Nishijima, Y., Sridhar, A., Hamlin, R. L., et al. (2011). The relationship between arrhythmogenesis and impaired contractility in heart failure: role of altered ryanodine receptor function. Cardiovasc. Res. 90, 493-502. doi: 10.1093/cvr/cvr025
9. Bell, J. R., Vila-Petroff, M., and Delbridge, L. M. D. (2014). CaMKII-dependent responses to ischemia and reperfusion challenges in the heart. Front. Pharmacol. 5:96. doi: 10.3389/fphar.2014.00096
10. Bers, D. M., and Grandi, E. (2009). Calcium/calmodulin-dependent kinase II regulation of cardiac ion channels. J. Cardiovasc. Pharmacol. 54, 180-187. doi: 10.1097/FJC.0b013e3181a25078
11. Camors, E., and Valdivia, H. H. (2014). CaMKII Regulation of cardiac ryanodine receptors and inositol triphosphate receptors. Front. Pharmacol. 5:101. doi: 10.3389/fphar.2014.00101
12. Camors, E., Mohler, P. J., Bers, D. M., and Despa, S. (2012). Ankyrin-B reduction enhances Ca spark-mediated SR Ca release promoting cardiac myocyte arrhythmic activity. J. Mol. Cell. Cardiol. 52, 1240-1248. doi: 10.1016/j.yjmcc.2012.02.010
13. Cerrone, M., Napolitano, C., and Priori, S. G. (2012). Genetics of ion-channel disorders. Curr. Opin. Cardiol. 27, 242-252. doi: 10.1097/HCO.0b013e328352429d
14. Chakir, K., Daya, S. K., Tunin, R. S., Helm, R. H., Byrne, M. J., Dimaano, V. L., et al. (2008). Reversal of global apoptosis and regional stress kinase activation by cardiac resynchronization. Circulation 117, 1369-1377. doi: 10.1161/CIRCULATIONAHA.107.706291
15. 2+ channel function during Timothy syndrome by ablation of an anchoring protein. Circ. Res. 109, 255-261. doi: 10.1161/CIRCRESAHA.111.248252
16. Cheng, J., Xu, L., Lai, D., Guilbert, A., Lim, H. J., Keskanokwong, T., et al. (2012). CaMKII inhibition in heart failure, beneficial, harmful, or both. Am. J. Physiol. Heart Circ. Physiol. 302, H1454-H1465. doi: 10.1152/ajpheart.00812.2011
17. Curran, J., Brown, K. H., Santiago, D. J., Pogwizd, S., Bers, D. M., and Shannon, T. R. (2010). Spontaneous Ca waves in ventricular myocytes from failing hearts depend on Ca(2+)-calmodulin-dependent protein kinase II. J. Mol. Cell. Cardiol. 49, 25-32. doi: 10.1016/j.yjmcc.2010.03.013
18. Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., and Keating, M. T. (1995). A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 80, 795-803. doi: 10.1016/0092-8674(95)90358-5
19. DeGrande, S., Nixon, D., Koval, O., Curran, J. W., Wright, P., Wang, Q., et al. (2012). CaMKII inhibition rescues proarrhythmic phenotypes in the model of human ankyrin-B syndrome. Heart Rhythm 9, 2034-2041. doi: 10.1016/j.hrthm.2012.08.026
20. Di Pasquale, E., Lodola, F., Miragoli, M., Denegri, M., Avelino-Cruz, J. E., Buonocore, M., et al. (2013). CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. Cell Death Dis. 4:e843. doi: 10.1038/cddis.2013.369
21. Drum, B. M., Dixon, R. E., Yuan, C., Cheng, E. P., and Santana, L. F. (2014). Cellular mechanisms of ventricular arrhythmias in a mouse model of Timothy syndrome (long QT syndrome 8). J. Mol. Cell. Cardiol. 66, 63-71. doi: 10.1016/j.yjmcc.2013.10.021
22. 2+ handling and increased mortality. J. Am. Coll. Cardiol. 57, 469-479. doi: 10.1016/j.jacc.2010.08.639
23. Dzhura, I., Wu, Y., Colbran, R. J., Balser, J. R., and Anderson, M. E. (2000). Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat. Cell Biol. 2, 173-177. doi: 10.1038/35004052
24. El-Haou, S., Balse, E., Neyroud, N., Dilanian, G., Gavillet, B., Abriel, H., et al. (2009). Kv4 potassium channels form a tripartite complex with the anchoring protein SAP97 and CaMKII in cardiac myocytes. Circ. Res. 104, 758-769. doi: 10.1161/CIRCRESAHA.108.191007
25. Erickson, J. R. (2014). Mechanisms of CaMKII activation in the heart. Front. Pharmacol. 5:59. doi: 10.3389/fphar.2014.00059
26. Erxleben, C., Liao, Y., Gentile, S., Chin, D., Gomez-Alegria, C., Mori, Y., et al. (2006). Cyclosporin and Timothy syndrome increase mode 2 gating of CaV1.2 calcium channels through aberrant phosphorylation of S6 helices. Proc. Natl. Acad. Sci. U.S.A. 103, 3932-3937. doi: 10.1073/pnas.0511322103
27. Fischer, T. H., Herting, J., Tirilomis, T., Renner, A., Neef, S., Toischer, K., et al. (2013a). Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology. Circulation 128, 970-981. doi: 10.1161/CIRCULATIONAHA.113.001746
28. Fischer, T. H., Neef, S., and Maier, L. S. (2013b). The Ca-calmodulin dependent kinase II: a promising target for future antiarrhythmic therapies? J. Mol. Cell. Cardiol. 58, 182-187. doi: 10.1016/j.yjmcc.2012.11.003
29. Gonano, L. A., Sepúlveda, M., Rico, Y., Kaetzel, M., Valverde, C. A., Dedman, J., et al. (2011). Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias. Circ. Arrhythm. Electrophysiol. 4, 947-957. doi: 10.1161/CIRCEP.111.964908
30. Grandi, E., and Herren, A. W. (2014). CaMKII-dependent regulation of cardiac Na+ homeostasis. Front. Pharmacol. 5:41. doi: 10.3389/fphar.2014.00041
31. Gray, C. B. B., and Heller Brown, J. (2014). CaMKIIdelta subtypes: localization and function. Front. Pharmacol. 5:15. doi: 10.3389/fphar.2014.00015
32. 2+ channels and ryanodine receptors in the heart. Front. Pharmacol. 5:60. doi: 10.3389/fphar.2014.00060
33. Guo, T., Zhang, T., Mestril, R., and Bers, D. M. (2006). Ca2+/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes. Circ. Res. 99, 398-406. doi: 10.1161/01.RES.0000236756.06252.13
34. Hashambhoy, Y. L., Greenstein, J. L., and Winslow, R. L. (2010). Role of CaMKII in RyR leak, EC coupling and action potential duration: a computational model. J. Mol. Cell. Cardiol. 49, 617-624. doi: 10.1016/j.yjmcc.2010.07.011
35. Heijman, J., Voigt, N., Wehrens, X. H. T., and Dobrev, D. (2014). Calcium dysregulation in atrial fibrillation: the role of CaMKII. Front. Pharmacol. 5:30. doi: 10.3389/fphar.2014.00030
36. Herren, A. W., Bers, D. M., and Grandi, E. (2013). Post-translational modifications of the cardiac Na channel: contribution of CaMKII-dependent phosphorylation to acquired arrhythmias. Am. J. Physiol. Heart Circ. Physiol. 305, H431-H445. doi: 10.1152/ajpheart.00306.2013
37. Ho, H. T., Liu, B., Snyder, J. S., Lou, Q., Brundage, E. A., Velez-Cortes, F., et al. (2013). Ryanodine receptor phosphorylation by oxidized CaMKII contributes to the cardiotoxic effects of cardiac glycosides. Cardiovasc. Res. 101, 165-174. doi: 10.1093/cvr/cvt233
38. Hoch, B., Meyer, R., Hetzer, R., Krause, E. G., and Karczewski, P. (1999). Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ. Res. 84, 713-721. doi: 10.1161/01.RES.84.6.713
39. 2+ handling, but accelerates cardiac remodeling in mice overexpressing CaMKIIdC. J. Mol. Cell. Cardiol. 50, 230-238. doi: 10.1016/j.yjmcc.2010.10.014
40. Hullin, R., Matthes, J., von Vietinghoff, S., Bodi, I., Rubio, M., D'Souza, K., et al. (2007). Increased expression of the auxiliary beta(2)-subunit of ventricular L-type Ca(2)+ channels leads to single-channel activity characteristic of heart failure. PLoS ONE 2:e292. doi: 10.1371/journal.pone.0000292
41. Hund, T. J., Koval, O. M., Li, J., Wright, P. J., Qian, L., Snyder, J. S., et al. (2010). A ß(IV)-spectrin/CaMKII signaling complex is essential for membrane excitability in mice. J. Clin. Invest. 120, 3508-3519. doi: 10.1172/JCI43621
42. Joiner, M.-L. A., and Koval, O. M. (2014). CaMKII and stress mix it up in mitochondria. Front. Pharmacol. 5:67. doi: 10.3389/fphar.2014.00067
43. 2+/calmodulin-dependent protein kinases of cardiac sarcoplasmic reticulum. Basic Res. Cardiol. 92(Suppl. 1), 37-43. doi: 10.1007/BF00794066
44. Kirchhefer, U., Schmitz, W., Scholz, H., and Neumann, J. (1999). Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc. Res. 42, 254-261. doi: 10.1016/S0008-6363(98)00296-X
45. Koval, O. M., Guan, X., Wu, Y., Joiner, M. L., Gao, Z., Chen, B., et al. (2010). CaV1.2 beta-subunit coordinates CaMKII-triggered cardiomyocyte death and afterdepolarizations. Proc. Natl. Acad. Sci. U.S.A. 107, 4996-5000. doi: 10.1073/pnas.0913760107
46. Koval, O. M., Snyder, J. S., Wolf, R. M., Pavlovicz, R. E., Glynn, P., Curran, J., et al. (2012). C2+/calmodulin-dependent protein kinase II-based regulation of voltage-gated Na+ channel in cardiac disease. Circulation 126, 2084-2094. doi: 10.1161/CIRCULATIONAHA.112.105320
47. Li, J., Marionneau, C., Zhang, R., Shah, V., Hell, J. W., Nerbonne, J. M., et al. (2006). Calmodulin kinase II inhibition shortens action potential duration by upregulation of K+ currents. Circ. Res. 99, 1092-1099. doi: 10.1161/01.RES.0000249369.71709.5c
48. Liu, N., Ruan, Y., Denegri, M., Bachetti, T., Li, Y., Colombi, B., et al. (2011). Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. J. Mol. Cell. Cardiol. 50, 214-222. doi: 10.1016/j.yjmcc.2010.10.001
49. Lu, Y. M., Huang, J., Shioda, N., Fukunaga, K., Shirasaki, Y., Li, X. M., et al. (2011). CaMKIIdB mediates aberrant NCX1 expression and the imbalance of NCX1/SERCA in transverse aortic constriction-induced failing heart. PLoS ONE 6:e24724. doi: 10.1371/journal.pone.0024724
50. Luczak, E. D., and Anderson, M. E. (2014). CaMKII oxidative activation and the pathogenesis of cardiac disease. J. Mol. Cell. Cardiol. doi: 10.1016/j.yjmcc.2014.02.004 [Epub ahead of print].
51. Luo, M., Guan, X., Luczak, E. D., Lang, D., Kutschke, W., Gao, Z., et al. (2013). Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. J. Clin. Invest. 123, 1262-1274. doi: 10.1172/JCI65268
52. 2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences. Am. J. Physiol. Heart Circ. Physiol. 294, H1597-H1608. doi: 10.1152/ajpheart.00484.2007
53. Mani, S. K., Egan, E. A., Addy, B. K., Grimm, M., Kasiganesan, H., Thiyagarajan, T., et al. (2010). beta-Adrenergic receptor stimulated Ncx1 upregulation is mediated via a CaMKII/AP-1 signaling pathway in adult cardiomyocytes. J. Mol. Cell. Cardiol. 48, 342-351. doi: 10.1016/j.yjmcc.2009.11.007
54. Marks, M. L., Whisler, S. L., Clericuzio, C., and Keating, M. (1995). A new form of long QT syndrome associated with syndactyly. J. Am. Coll. Cardiol. 25, 59-64. doi: 10.1016/0735-1097(94)00318-K
55. Mohler, P. J., Schott, J.-J., Gramolini, A. O., Dilly, K. W., Guatimosim, S., duBell, W. H., et al. (2003). Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 421, 634-639. doi: 10.1038/nature01335
56. Mohler, P. J., Splawski, I., Napolitano, C., Bottelli, G., Sharpe, L., Timothy, K., et al. (2004). A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Proc. Natl. Acad. Sci. U.S.A. 101, 9137-9142. doi: 10.1073/pnas.0402546101
57. Morotti, S., Edwards, A. G., McCulloch, A. D., Bers, D. M., and Grandi, E. (2014). A novel computational model of mouse myocyte electrophysiology to assess the synergy between Na+ loading and CaMKII. J. Physiol. doi: 10.1113/jphysiol.2013.266676
58. Mustroph, J., Maier, L. S., and Wagner, S. (2014). CaMKII regulation of cardiac K channels. Front. Pharmacol. 5:20. doi: 10.3389/fphar.2014.00020
59. Napolitano, C., Bloise, R., Monteforte, N., and Priori, S. G. (2012). Sudden cardiac death and genetic ion channelopathies: long QT, Brugada, short QT, catecholaminergic polymorphic ventricular tachycardia, and idiopathic ventricular fibrillation. Circulation 125, 2027-2034. doi: 10.1161/CIRCULATIONAHA.111.055947
60. Nattel, S., Burstein, B., and Dobrev, D. (2008). Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ. Arrhythm. Electrophysiol. 1, 62-73. doi: 10.1161/CIRCEP.107.754564
61. Nerbonne, J. M. (2004). Studying cardiac arrhythmias in the mouse-a reasonable model for probing mechanisms? Trends Cardiovasc. Med. 14, 83-93. doi: 10.1016/j.tcm.2003.12.006
62. Onal, B., Unudurthi, S. D., and Hund, T. J. (2014). Modeling CaMKII in cardiac physiology: from molecule to tissue. Front. Pharmacol. 5:9. doi: 10.3389/fphar.2014.00009
63. Paulussen, A., Matthijs, G., Gewillig, M., Verhasselt, P., Cohen, N., and Aerssens, J. (2003). Mutation analysis in congenital Long QT Syndrome-a case with missense mutations in KCNQ1 and SCN5A. Genet. Test. 7, 57-61. doi: 10.1089/109065703321560958
64. Pellicena, P., and Schulman, H. (2014). CaMKII inhibitors: from research tools to therapeutic agents. Front. Pharmacol. 5:21. doi: 10.3389/fphar.2014.00021
65. Priori, S. G., Napolitano, C., Memmi, M., Colombi, B., Drago, F., Gasparini, M., et al. (2002). Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106, 69-74. doi: 10.1161/01.CIR.0000020013.73106.D8
66. Purohit, A., Rokita, A. G., Guan, X., Chen, B., Koval, O. M., Voigt, N., et al. (2013). Oxidized Ca2+/calmodulin-dependent protein kinase II triggers atrial fibrillation. Circulation 128, 1748-1757. doi: 10.1161/CIRCULATIONAHA.113.003313
67. Respress, J. L., van Oort, R. J., Li, N., Rolim, N., Dixit, S. S., deAlmeida, A., et al. (2012). Role of RyR2 phosphorylation at S2814 during heart failure progression. Circ. Res. 110, 1474-1483. doi: 10.1161/CIRCRESAHA.112.268094
68. Ronkainen, J. J., Hänninen, S. L., Korhonen, T., Koivumäki, J. T., Skoumal, R., Rautio, S., et al. (2011). Ca2+-calmodulin-dependent protein kinase II represses cardiac transcription of the L-type calcium channel alpha(1C)-subunit gene (Cacna1c) by DREAM translocation. J. Physiol. 589, 2669-2686. doi: 10.1113/jphysiol.2010.201400
69. Sag, C. M., Wadsack, D. P., Khabbazzadeh, S., Abesser, M., Grefe, C., Neumann, K., et al. (2009). Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure. Circ. Heart Fail. 2, 664-675. doi: 10.1161/CIRCHEARTFAILURE.109.865279
70. 2+/calmodulin-dependent protein kinase II. Am. J. Physiol. Heart Circ. Physiol. 295, H1669-H1683. doi: 10.1152/ajpheart.00010.2008
71. Said, M., Becerra, R., Valverde, C. A., Kaetzel, M. A., Dedman, J. R., Mundiña-Weilenmann, C., et al. (2011). Calcium-calmodulin dependent protein kinase II (CaMKII): a main signal responsible for early reperfusion arrhythmias. J. Mol. Cell. Cardiol. 51, 936-944. doi: 10.1016/j.yjmcc.2011.08.010
72. Schröder, F., Handrock, R., Beuckelmann, D. J., Hirt, S., Hullin, R., Priebe, L., et al. (1998). Increased availability and open probability of single L-type calcium channels from failing compared with nonfailing human ventricle. Circulation 98, 969-976. doi: 10.1161/01.CIR.98.10.969
73. Splawski, I., Timothy, K. W., Decher, N., Kumar, P., Sachse, F. B., Beggs, A. H., et al. (2005). Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl. Acad. Sci. U.S.A. 102, 8089-8096. doi: 10.1073/pnas.0502506102
74. Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., et al. (2004). Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19-31. doi: 10.1016/j.cell.2004.09.011
75. Swaminathan, P. D., Purohit, A., Hund, T. J., and Anderson, M. E. (2012). Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ. Res. 110, 1661-1677. doi: 10.1161/CIRCRESAHA.111.243956
76. Swaminathan, P. D., Purohit, A., Soni, S., Voigt, N., Singh, M. V., Glukhov, A. V., et al. (2011). Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J. Clin. Invest. 121, 3277-3288. doi: 10.1172/JCI57833
77. Tessier, S., Karczewski, P., Krause, E. G., Pansard, Y., Acar, C., Lang-Lazdunski, M., et al. (1999). Regulation of the transient outward K(+) current by Ca(2+)/calmodulin-dependent protein kinases II in human atrial myocytes. Circ. Res. 85, 810-819. doi: 10.1161/01.RES.85.9.810
78. Tester, D. J., Valdivia, C., Harris-Kerr, C., Alders, M., Salisbury, B. A., Wilde, A. A., et al. (2010). Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation. Heart Rhythm 7, 912-919. doi: 10.1016/j.hrthm.2010.04.014
79. Tester, D. J., Will, M. L., Haglund, C. M., and Ackerman, M. J. (2005). Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2, 507-517. doi: 10.1016/j.hrthm.2005.01.020
80. Thiel, W. H., Chen, B., Hund, T. J., Koval, O. M., Purohit, A., Song, L. S., et al. (2008). Proarrhythmic defects in Timothy syndrome require calmodulin kinase II. Circulation 118, 2225-2234. doi: 10.1161/CIRCULATIONAHA.108.788067
81. Toischer, K., Hartmann, N., Wagner, S., Fischer, T. H., Herting, J., Danner, B. C., et al. (2013). Role of late sodium current as a potential arrhythmogenic mechanism in the progression of pressure-induced heart disease. J. Mol. Cell. Cardiol. 61, 111-122. doi: 10.1016/j.yjmcc.2013.03.021
82. Tomaselli, G. F., and Marbán, E. (1999). Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc. Res. 42, 270-283. doi: 10.1016/S0008-6363(99)00017-6
83. Valdivia, C. R., Chu, W. W., Pu, J., Foell, J. D., Haworth, R. A., Wolff, M. R., et al. (2005). Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J. Mol. Cell. Cardiol. 38, 475-483. doi: 10.1016/j.yjmcc.2004.12.012
84. van Oort, R. J., McCauley, M. D., Dixit, S. S., Pereira, L., Yang, Y., Respress, J. L., et al. (2010). Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure. Circulation 122, 2669-2679. doi: 10.1161/CIRCULATIONAHA.110.982298
85. 2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 125, 2059-2070. doi: 10.1161/CIRCULATIONAHA.111.067306
86. Wagner, S., Dybkova, N., Rasenack, E. C., Jacobshagen, C., Fabritz, L., Kirchhof, P., et al. (2006). Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. J. Clin. Invest. 116, 3127-3138. doi: 10.1172/JCI26620
87. Wagner, S., Hacker, E., Grandi, E., Weber, S. L., Dybkova, N., Sossalla, S., et al. (2009). Ca/calmodulin kinase II differentially modulates potassium currents. Circ. Arrhythm. Electrophysiol. 2, 285-294. doi: 10.1161/CIRCEP.108.842799
88. Watanabe, H., and Knollmann, B. C. (2011). Mechanism underlying catecholaminergic polymorphic ventricular tachycardia and approaches to therapy. J. Electrocardiol. 44, 650-655. doi: 10.1016/j.jelectrocard.2011.07.025
89. 2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ. Res. 94, e61-e70. doi: 10.1161/01.RES.0000125626.33738.E2
90. Witcher, D. R., Kovacs, R. J., Schulman, H., Cefali, D. C., and Jones, L. R. (1991). Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J. Biol. Chem. 266, 11144-11152.
91. Wu, Y., and Anderson, M. E. (2014). CaMKII in sinoatrial node physiology and dysfunction. Front. Pharmacol. 5:48. doi: 10.3389/fphar.2014.00048
92. 2+ signaling in cardiac myocyte excitation-transcription coupling. J. Clin. Invest. 116, 675-682. doi: 10.1172/JCI27374
93. Yaniv, Y., and Maltsev, V. A. (2014). Numerical modeling calcium and CaMKII effects in the SA node. Front. Pharmacol. 5:58. doi: 10.3389/fphar.2014.00058
94. Yao, L., Fan, P., Jiang, Z., Viatchenko-Karpinski, S., Wu, Y., Kornyeyev, D., et al. (2011). Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice. Am. J. Physiol. Cell Physiol. 301, C577-C586. doi: 10.1152/ajpcell.00125.2011
95. Yarotskyy, V., Gao, G., Peterson, B. Z., and Elmslie, K. S. (2009). The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation. J. Physiol. 587, 551-565. doi: 10.1113/jphysiol.2008.161737
96. Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., et al. (2011). Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature 471, 230-234. doi: 10.1038/nature09855
97. Yong, S., Tian, X., and Wang, Q. (2003). LQT4 gene: the "missing" ankyrin. Mol. Interv. 3, 131-136. doi: 10.1124/mi.3.3.131
98. Yuan, W., and Bers, D. M. (1994). Ca-dependent facilitation of cardiac Ca current is due to Ca-calmodulin-dependent protein kinase. Am. J. Physiol. 267, H982-H993.
99. Zhang, T., Maier, L. S., Dalton, N. D., Miyamoto, S., Ross, J., Bers, D. M., et al. (2003). The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ. Res. 92, 912-919. doi: 10.1161/01.RES.0000069686.31472.C5